Compared with opioids, other high impact drug classes like topicals, compound kits, combo packs, and specialty medications, represent proportionately low volume. However, they can be associated with exponentially significant costs. Recognizing the trends related to such cost drivers can help promote clinically-appropriate savings. Watch the video blog to learn more.
More stories
From Operational Burden to Financial Breakthrough
When medical bill review is managed by internal teams, performance depends on sustaining specialized expertise and the ability to scale operations in the face of turnover, volume volatility and unexpected disruptions. For many payers, as bill volumes fluctuate and labor pressures increase, sustaining consistent turnaround times and maximizing savings can place growing demands on internal teams.
Specialty Solutions Spotlight: Managing Medical Device Warranties in Workers’ Compensation
Not all durable medical equipment (DME) referrals are completed at purchase. Some include warranties that need to be monitored and maintained, including items like wheelchairs, respiratory equipment, prosthetics and patient lifts.
Driving Surgical Cost Savings Through Expanded Utilization Review
Expanded utilization review helped a self-insured employer control rising surgical costs, reduce unnecessary procedures, and generate over $1M in savings while maintaining a two-day review turnaround.
Business Insurance Video: Comp Spotlight with Michele Hibbert
See Michele Hibbert break down the impact of new state legislation on AI-powered claims processes in this exclusive Business Insurance "Comp Spotlight" interview.
New York Provides Data-Backed Proof That Stronger Utilization Review is a Cost-Control Strategy
Read how New York's strategic utilization review expansion kept medical payments stable despite rising costs nationwide.
Settling Future Medical? Don’t Let Medicare Turn It Into a Reopen
Discover how to prevent Medicare from disrupting your settled claims. Learn when MSAs are needed, what documentation to gather upfront, and strategic approaches to identify cost drivers.